Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Non-Current Assets: 2013-2025

Historic Non-Current Assets for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $23.9 million.

  • Ocular Therapeutix's Non-Current Assets rose 37.70% to $23.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 37.70%. This contributed to the annual value of $16.9 million for FY2024, which is 14.51% down from last year.
  • As of Q3 2025, Ocular Therapeutix's Non-Current Assets stood at $23.9 million, which was up 33.10% from $18.0 million recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Non-Current Assets registered a high of $23.9 million during Q3 2025, and its lowest value of $12.7 million during Q2 2022.
  • Its 3-year average for Non-Current Assets is $19.7 million, with a median of $19.1 million in 2024.
  • As far as peak fluctuations go, Ocular Therapeutix's Non-Current Assets spiked by 71.35% in 2023, and later dropped by 17.84% in 2024.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Non-Current Assets stood at $13.6 million in 2021, then spiked by 44.71% to $19.7 million in 2022, then grew by 0.83% to $19.8 million in 2023, then dropped by 14.51% to $16.9 million in 2024, then soared by 37.70% to $23.9 million in 2025.
  • Its Non-Current Assets was $23.9 million in Q3 2025, compared to $18.0 million in Q2 2025 and $18.2 million in Q1 2025.